1. Anticancer Potential of Damnacanthal and Nordamnacanthal from Morinda elliptica Roots on T-lymphoblastic Leukemia Cells.
- Author
-
Latifah, Saiful Yazan, Gopalsamy, Banulata, Abdul Rahim, Raha, Manaf Ali, Abdul, Haji Lajis, Nordin, and Rakotondraibe, Harinantenaina Liva
- Subjects
CELL cycle ,LEUKEMIA ,CELL analysis ,PROTEIN synthesis ,CELL lines - Abstract
Background: This study reports on the cytotoxic properties of nordamnacanthal and damnacanthal, isolated from roots of Morinda elliptica on T-lymphoblastic leukaemia (CEM-SS) cell lines. Methods: MTT assay, DNA fragmentation, ELISA and cell cycle analysis were carried out. Results: Nordamnacanthal and damnacanthal at IC
50 values of 1.7 μg/mL and10 μg/mL, respectively. At the molecular level, these compounds caused internucleosomal DNA cleavage producing multiple 180–200 bp fragments that are visible as a "ladder" on the agarose gel. This was due to the activation of the Mg2+ /Ca2+ -dependent endonuclease. The induction of apoptosis by nordamnacanthal was different from the one induced by damnacanthal, in a way that it occurs independently of ongoing transcription process. Nevertheless, in both cases, the process of dephosphorylation of protein phosphates 1 and 2A, the ongoing protein synthesis and the elevations of the cytosolic Ca2+ concentration were not needed for apoptosis to take place. Nordamnacanthal was found to have a cytotoxic effect by inducing apoptosis, while damnacanthal caused arrest at the G0/G1 phase of the cell cycle. Conclusion: Damnacanthal and nordamnacanthal have anticancer properties, and could act as potential treatment for T-lymphoblastic leukemia. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF